Back to Search
ROBERT SIMMS, MD
MD
Rheumatology Physician
NPI: 1235101429IndividualAccepts Medicare
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
20298(NH)
CMS Specialties
PrimaryRHEUMATOLOGY
Education
UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY
Class of 1980
Research & Publications (20)
Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression.
PMID 19543397·PLoS One·2009
8-other
The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes.
PMID 19536281·PLoS One·2009
8-other
Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial.
PMID 19333948·Arthritis Rheum·2009
3-trial
MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial.
PMID 19248104·Arthritis Rheum·2009
4-observational
B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis.
PMID 19180481·Arthritis Rheum·2009
3-trial
A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease.
PMID 18512816·Arthritis Rheum·2008
4-observational
Nephrocystin-1 interacts directly with Ack1 and is expressed in human collecting duct.
PMID 18477472·Biochem Biophys Res Commun·2008
8-other
ANCA-associated renal vasculitis following anti-tumor necrosis factor alpha therapy.
PMID 18295046·Am J Kidney Dis·2008
5-case
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.
PMID 17717203·Am J Respir Crit Care Med·2007
4-observational
Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis.
PMID 17485423·Ann Rheum Dis·2007
4-observational
Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.
PMID 17469162·Arthritis Rheum·2007
2-rct
Durometry for the assessment of skin disease in systemic sclerosis.
PMID 16874783·Arthritis Rheum·2006
4-observational
Cyclophosphamide versus placebo in scleroderma lung disease.
PMID 16790698·N Engl J Med·2006
4-observational
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.
PMID 15593188·Arthritis Rheum·2004
3-trial
A qualitative study of substance use and sexual behavior among 18- to 29-year-old men while incarcerated in the United States.
PMID 15539547·Health Educ Behav·2004
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 MEDICAL CENTER DR
LEBANON, NH 03756 - Phone
- (603) 650-8622
Quick Facts
- NPI
- 1235101429
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 46
- Publications
- 20
Are you this provider?
Claim Your Profile